✦ LIBER ✦

Influence of Hepatic Impairment on the Pharmacokinetics and Safety Profile of Dapagliflozin: An Open-Label, Parallel-Group, Single-Dose Study

✍ Scribed by Sreeneeranj Kasichayanula; Xiaoni Liu; Weijiang Zhang; Marc Pfister; Frank P. LaCreta; David W. Boulton

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of hepatic impairment on the pha

✍ Ophelia Q.P. Yin; Neil Gallagher; Chiaki Tanaka; Deirdre Fisher; Venkat Sethuram 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 144 KB

An Open-Label, Single-Dose, Parallel-Gro

✍ Baird-Bellaire, Susan; Behrle, Jessica A.; Parker, Vernon D.; Patat, Alain; Paul 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 267 KB

Effects of Hepatic Impairment on the Pha

✍ Peveling-Oberhag, Jan; Zeuzem, Stefan; Yong, Wei Peng; Kunz, Tiffany; Paquet, Th 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 994 KB

Single- and Multiple-Dose Pharmacokineti

✍ Mitchell, Malcolm; Kothare, Prajakti; Bergstrom, Richard; Zhao, Fangyi; Jen, Kai 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 419 KB

Effects of hepatic impairment on the ste

✍ Monika Schöller-Gyüre; Thomas N. Kakuda; Goedele De Smedt; Brian Woodfall; Cindy 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 851 KB

An open-label study to estimate the effe

✍ Moore, Kenneth T.; Vaidyanathan, Seema; Natarajan, Jaya; Ariyawansa, Jay; Haskel 📂 Article 📅 2014 🏛 Sage Publications 🌐 English ⚖ 473 KB